The MarketWatch News Department was not involved in the creation of this content. Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative ...
The latest update is out from Hyperfine ( (HYPR)). On December 29, 2025, Hyperfine, Inc. amended and restated its existing at-the-market equity offering arrangement, expanding its distribution ...
India's Central Drugs Standard Control Organization (CDSCO) has approved the Hyperfine Swoop system, opening a major global market. Commercial launch to begin early 2026. Hyperfine, Inc. (Nasdaq: HYPR ...
Hyperfine Inc., a Guilford-based biotechnology company, said Wednesday it has received a $3.7 million grant from the Bill & Melinda Gates Foundation to advance development of its AI-powered portable ...
Hyperfine outlines $5M-$6M Q4 revenue target and accelerated growth following next-gen system launch
Maria Sainz, CEO, announced that the third quarter marked an important new beginning for Hyperfine, citing the launches of the next-generation swoop system and Opti AI software as major catalysts. She ...
Sainz said, "Market interest and demand for our next-generation system is very strong," directly asserting visible commercial traction behind the new technology. Hale said, "the fourth quarter is the ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Hyperfine ( (HYPR)) has provided an ...
Hyperfine shares were 42% lower, at $1.28, after the company priced an underwritten public offering of 14 million shares at $1.25 a share. All of the shares in the offering are being sold by Hyperfine ...
Hyperfine Inc., a Guilford-based medical imaging technology company, has priced its underwritten public offering of 14 million shares of its Class A common stock at $1.25 per share, the company said ...
Abstract: We plan to directly measure the hyperfine structure of the ground-state positronium. The hyperfine structure between ortho-positronium and para-positronium is about 203 GHz. We develop a new ...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic ...
Hyperfine, Inc. (HYPR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results